EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Eriodictyol in Cancer Therapy: Reviewing Mechanistic Insights and Translational Opportunities

Sohail Mumtaz iD, Juie Nahushkumar Rana, Kainat Gul

International Journal of Molecular Sciences · 24.03.2026 · 27 (7) · 2924

DOI: 10.3390/ijms27072924 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.03.2026. Verfasst von Sohail Mumtaz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biological Engineering, Gachon University, 1342 Seongnamdaero, Sujeong-gu, Seongnam-si 13120, Republic of Korea. Hauptthemen laut MEDLINE: Flavanones, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Eriodictyol, a naturally occurring flavanone, has appeared as a biologically versatile compound with increasing relevance in biomedical research, especially in cancers. Evidence over the past few decades indicates that eriodictyol influences cancer cell fate through coordinated modulation of cell-cycle control, survival, and regulated cell death pathways. Eriodictyol appears to reshape oncogenic signaling networks, including PI3K/Akt/mTOR and associated kinase cascades, thereby restricting proliferative capacity and lowering resistance thresholds. Studies consistently report cell-cycle arrest at critical checkpoints, accompanied by activation of both mitochondrial- and death-receptor-mediated apoptotic pathways through disruption of BCL-2 family balance, caspase engagement, and mitochondrial destabilization. Furthermore, eriodictyol alters intracellular redox dynamics in a dose-dependent manner, selectively sensitizing cancer cells to oxidative and metabolic stress. More recent findings extend its significance to inflammation-driven tumor progression and to the regulation of ferroptosis. Beyond intrinsic pharmacological activity, advances in nanocarrier-based delivery and balanced combination strategies have started to address critical challenges and limitations regarding solubility and bioavailability, while allowing precise therapeutic applications. In this review, we have discussed the plausible mechanisms, experimental evidence, and translational insights of eriodictyol as a systems-level modulator of cancer biology. We also outlined research priorities essential for progressing its clinical relevance as future perspectives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavanonesNeoplasmsAntineoplastic AgentsHumansAnimalsSignal TransductionApoptosis

Stichwörter der Autor:innen

apoptosis and ferroptosiscancer signaling pathwayscombination therapyeriodictyolnanomedicine and drug delivery

Substanzen

FlavanoneseriodictyolAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Chemical and Biological Engineering, Gachon University, 1342 Seongnamdaero, Sujeong-gu, Seongnam-si 13120, Republic of Korea.
  • Fels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA.
  • Department of Botany, Hazara University, Mansehra 21300, Pakistan.

ORCID-Profile: Sohail Mumtaz

Zitieren

APA

Mumtaz, S., Rana, J. N., & Gul, K. (2026). Eriodictyol in Cancer Therapy: Reviewing Mechanistic Insights and Translational Opportunities. International Journal of Molecular Sciences, 27(7), 2924. https://doi.org/10.3390/ijms27072924

Vancouver

Mumtaz S, Rana JN, Gul K. Eriodictyol in Cancer Therapy: Reviewing Mechanistic Insights and Translational Opportunities. International Journal of Molecular Sciences. 2026;27(7):2924. doi:10.3390/ijms27072924

BibTeX
@article{Mumtaz2026,
  author = {Mumtaz, Sohail and Rana, Juie Nahushkumar and Gul, Kainat},
  title = {Eriodictyol in Cancer Therapy: Reviewing Mechanistic Insights and Translational Opportunities},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {7},
  pages = {2924},
  doi = {10.3390/ijms27072924}
}
Kostenlos starten →